Actinic Keratosis Olsen Grade I/II Clinical Trial
Official title:
Three-armed, Randomized, Double-blind Dose-finding Trial on Efficiency and Safety of AK 3012 in 3 Different Concentrations in Patients With Actinic Keratosis Olsen Grade I/II
In this three-armed dose-finding trial 3 AK 3012 topical formulations shall be investigated
with respect to safety and efficacy in order to identify the optimal concentration in the
topical formulation.
The main objective of the trial is to determine the optimal concentration of the active
agent in the topical formulation as quantified by the change of the number of skin
alterations in pre-defined areas in a time period from inclusion in the trial until the end
of treatment (3 months) or prior complete healing.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment